RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare
Director Lynn A. Tetrault sold $3.7M of Rhythm Pharmaceuticals, Inc.
Sold$3,711,896
$100.32Price
37,000Shares
−84%Stake
What RYTM did after the filing
- The stock from Thu, Jun 25 open, $107.19
- +7.9%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 7 close.
Traded Mon, Jun 22. Filed Wed, Jun 24, 4:15 PM ET, after the close. Returns use the Jun 25 open and the Aug 7 close. Not investment advice.